Birzeit Pharmaceuticals Company (PLSE: BPC)
Health Care · Pharmaceuticals · PS
$3.61
-0.82% today · -2.4% 1Y
Birzeit Pharmaceuticals Company (PLSE: BPC) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $139.94M.
Over the last twelve months the share price has lost 2.4%, trading between 3.57 and 4.45.
Tweenvest scores Birzeit Pharmaceuticals Company across four factors: quality 79/100, value 63/100, growth 35/100, dividend 29/100. Its strongest factor is quality.
BPC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $139.94M
- Revenue (TTM)
- $46.66M
- P/E
- 12.99
- EPS
- 0.28
- Dividend yield
- 1.39%
- Beta (5Y)
- -0.12
- 52-week high
- $4.45
- 52-week low
- $3.57
- Avg volume (3M)
- —
- Shares outstanding
- 38.76M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.47 | +0.12% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF375.40 | +0.43% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.86 | -0.72% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.51 | -0.21% |
Figures last refreshed Aug 18, 2026.